MSB Preliminary Final Report including Appendix 4E 30/08/18 PRICE SENSITIVE download Created with Sketch. 1.6MB Share MSB UPDATE ON TASLY TRANSACTION 29/08/18 PRICE SENSITIVE download Created with Sketch. 89.39KB Share MSB Appendix 4C - quarterly 31/07/18 PRICE SENSITIVE download Created with Sketch. 117.52KB Share MSB Initial Director's Interest Notice 18/07/18 download Created with Sketch. 62.49KB Share MSB MSB Enters Into Cardiovascular Alliance For China With Tasly 17/07/18 PRICE SENSITIVE download Created with Sketch. 80.49KB Share MSB Director Appointment/Resignation 11/07/18 download Created with Sketch. 89.85KB Share MSB Appendix 3B 10/07/18 download Created with Sketch. 184.33KB Share MSB MSB Enters Into US$50M Financing With NovaQuest Capital 02/07/18 PRICE SENSITIVE download Created with Sketch. 80.37KB Share MSB Initial and Final Directors' Interest Notices 25/06/18 download Created with Sketch. 140.45KB Share MSB ISSCR Presentation on P3 GVHD Trial Survival Benefits 22/06/18 download Created with Sketch. 1.77MB Share MSB Key Day 100 Survival Results In P3 GvHD Trial 21/06/18 PRICE SENSITIVE download Created with Sketch. 76.22KB Share MSB Director Appointment/Resignation 19/06/18 download Created with Sketch. 74.62KB Share MSB MSB Provides Q3 Financial Results and Operational Highlights 31/05/18 download Created with Sketch. 212.11KB Share MSB Mesoblast Appoints New Chief Financial Officer 31/05/18 download Created with Sketch. 74.97KB Share MSB Third Quarter Results Presentation 31/05/18 download Created with Sketch. 965.73KB Share MSB Third Quarter Financial Results on Form 6-K 31/05/18 PRICE SENSITIVE download Created with Sketch. 515.82KB Share MSB Partnership For Allogeneic Cell-based Cancer Immunotherapies 29/05/18 PRICE SENSITIVE download Created with Sketch. 77.36KB Share MSB Cleansing notice and Appendix 3B 15/05/18 download Created with Sketch. 233.86KB Share MSB MSB P3 Results For GVHD Presented At ISCT Meeting 08/05/18 download Created with Sketch. 95.17KB Share MSB MSB Cell Therapies Featured At Vatican Healthcare Conference 01/05/18 download Created with Sketch. 73KB Share MSB Appendix 4C - quarterly 30/04/18 PRICE SENSITIVE download Created with Sketch. 114.44KB Share MSB MSB Clinical Program Update For MPC-150-IM In Heart Failure 18/04/18 download Created with Sketch. 106.86KB Share MSB Mesoblast Phase 3 CLBP Trial Completes Enrollment 29/03/18 download Created with Sketch. 99.5KB Share MSB Change in substantial holding 09/03/18 download Created with Sketch. 187.57KB Share MSB MSB Enters Into $75 Million Non-Dilutive Credit Facility 07/03/18 PRICE SENSITIVE download Created with Sketch. 91.99KB Share MSB Mesoblast Provides Half Year Results and Corporate Update 28/02/18 download Created with Sketch. 237.2KB Share MSB Half Year Results Presentation 28/02/18 download Created with Sketch. 3.21MB Share MSB Half Year Report and Accounts (including Appendix 4D) 28/02/18 PRICE SENSITIVE download Created with Sketch. 558.51KB Share MSB GVHD Day 28 Results Presentation 23/02/18 PRICE SENSITIVE download Created with Sketch. 1.85MB Share MSB Primary Endpoint Successfully Achieved in MSB P3 GVHD Trial 22/02/18 PRICE SENSITIVE download Created with Sketch. 103.81KB Share MSB Appendix 4C - quarterly 31/01/18 PRICE SENSITIVE download Created with Sketch. 96.37KB Share MSB Appendix 3B with prospectus 19/01/18 PRICE SENSITIVE download Created with Sketch. 481.29KB Share MSB Presentation to J.P. Morgan 2018 Healthcare Conference 12/01/18 download Created with Sketch. 3.6MB Share MSB Presentation at JP Morgan Healthcare Conference 11/01/18 download Created with Sketch. 69.98KB Share MSB Change of Director's Interest Notice 22/12/17 download Created with Sketch. 88.88KB Share MSB Mesoblast Receives RMAT For LVAD Heart Failure Patients 21/12/17 PRICE SENSITIVE download Created with Sketch. 86.83KB Share MSB Release of shares from voluntary escrow 20/12/17 download Created with Sketch. 83.61KB Share MSB Mesoblast's P3 GVHD Trial Completes Enrollment 20/12/17 PRICE SENSITIVE download Created with Sketch. 93.71KB Share MSB Mesoblast Grants TiGenix License For Treatment of Fistulae 15/12/17 PRICE SENSITIVE download Created with Sketch. 73.63KB Share MSB MSB Named Global Technology Leader In Cell Therapy Industry 08/12/17 PRICE SENSITIVE download Created with Sketch. 90.71KB Share MSB Change in substantial holding 07/12/17 download Created with Sketch. 280.18KB Share MSB Change in substantial holding 05/12/17 download Created with Sketch. 291.65KB Share MSB Response to ASX Aware Letter Query 17/11/17 PRICE SENSITIVE download Created with Sketch. 508.34KB Share MSB Results of Meeting 16/11/17 download Created with Sketch. 172.37KB Share MSB CEO Presentation to 2017 Annual General Meeting 16/11/17 download Created with Sketch. 3.72MB Share MSB Chairman's Address to Shareholders 16/11/17 download Created with Sketch. 93.39KB Share MSB Ceasing to be a substantial holder 15/11/17 download Created with Sketch. 2.58MB Share MSB Mesoblast Provides Corporate Update and Q1 Financial Results 15/11/17 PRICE SENSITIVE download Created with Sketch. 201.68KB Share MSB First Quarter Results Presentation 15/11/17 download Created with Sketch. 3.73MB Share MSB First Quarter Results On Form 6K 15/11/17 PRICE SENSITIVE download Created with Sketch. 366.77KB Share MSB Becoming a substantial holder 13/11/17 download Created with Sketch. 6.28MB Share MSB RA Phase 2 Trial Results Presented At ACR Annual Meeting 13/11/17 PRICE SENSITIVE download Created with Sketch. 127.42KB Share MSB Mesoblast Presents At Credit Suisse Healthcare Conference 09/11/17 download Created with Sketch. 71.96KB Share MSB Appendix 4C - quarterly 31/10/17 PRICE SENSITIVE download Created with Sketch. 113.37KB Share MSB Ceasing to be a substantial holder 30/10/17 download Created with Sketch. 1.06MB Share MSB Ceasing to be a substantial holder 27/10/17 download Created with Sketch. 117.71KB Share MSB Becoming a substantial holder 27/10/17 download Created with Sketch. 3.99MB Share MSB Annual Report to shareholders 16/10/17 download Created with Sketch. 2.81MB Share MSB Notice of Annual General Meeting/Proxy Form 16/10/17 download Created with Sketch. 299.88KB Share MSB Appendix 4G and Corporate Governance Statement 16/10/17 download Created with Sketch. 184.8KB Share MSB Appendix 3B 06/10/17 download Created with Sketch. 78.38KB Share MSB End-Stage Heart Failure Trial Completes Enrollment 28/09/17 PRICE SENSITIVE download Created with Sketch. 116.85KB Share MSB Mesoblast Corporate Updates at Healthcare Conferences 25/09/17 PRICE SENSITIVE download Created with Sketch. 90.75KB Share MSB Change of Director's Interest Notices 25/09/17 download Created with Sketch. 232.91KB Share MSB Appendix 3B 18/09/17 download Created with Sketch. 137.7KB Share MSB Mesoblast Completes A$50.7 Million Raise 15/09/17 download Created with Sketch. 86.49KB Share MSB Change of Director Interest and Substantial Holding Notices 06/09/17 download Created with Sketch. 321.52KB Share MSB Change in substantial holding 06/09/17 download Created with Sketch. 80.17KB Share MSB Retail Entitlement Offer 01/09/17 PRICE SENSITIVE download Created with Sketch. 682.6KB Share MSB Mesoblast Reports on Annual and Fourth Quarter Results 30/08/17 PRICE SENSITIVE download Created with Sketch. 262.07KB Share MSB Annual Financial Results Presentation 30/08/17 download Created with Sketch. 3.27MB Share MSB Preliminary Final Report including Appendix 4E 30/08/17 PRICE SENSITIVE download Created with Sketch. 1.33MB Share MSB Underwritten A$50.7M Raise Closes Institutional Allocation 29/08/17 PRICE SENSITIVE download Created with Sketch. 89.69KB Share MSB Cleansing notice 25/08/17 download Created with Sketch. 142.32KB Share MSB Appendix 3B 25/08/17 download Created with Sketch. 138.37KB Share MSB Fully Underwritten Entitlement Offer Presentation 25/08/17 download Created with Sketch. 3.69MB Share MSB Fully Underwritten A$50.7 Million Entitlement Offer 25/08/17 PRICE SENSITIVE download Created with Sketch. 171.9KB Share MSB Trading Halt 25/08/17 PRICE SENSITIVE download Created with Sketch. 333.06KB Share MSB Potential For Accelerated Market Entry In Advanced CHF 23/08/17 PRICE SENSITIVE download Created with Sketch. 92.24KB Share MSB Positive Results of MSB Therapy in Osteoarthritis Published 16/08/17 PRICE SENSITIVE download Created with Sketch. 111.07KB Share MSB Release of shares from voluntary escrow 08/08/17 download Created with Sketch. 83.69KB Share MSB Appendix 4C - quarterly 31/07/17 PRICE SENSITIVE download Created with Sketch. 96.32KB Share MSB Change in substantial holding 13/07/17 download Created with Sketch. 278.85KB Share MSB Cleansing notice and Appendix 3B 10/07/17 download Created with Sketch. 233.9KB Share MSB Mesoblast RA Results Presented At EULAR Congress 22/06/17 PRICE SENSITIVE download Created with Sketch. 73.88KB Share MSB MSB Provides Q3 Operational Highlights and Financial Results 25/05/17 PRICE SENSITIVE download Created with Sketch. 240.41KB Share MSB Third Quarter Results Presentation 25/05/17 download Created with Sketch. 2.93MB Share MSB Third Quarter Financial Results On Form 6-K 25/05/17 PRICE SENSITIVE download Created with Sketch. 3.9MB Share MSB Change of Director's Interest Notice 02/05/17 download Created with Sketch. 90.45KB Share MSB Appendix 4C - quarterly 28/04/17 PRICE SENSITIVE download Created with Sketch. 97.45KB Share MSB Change in substantial holding 24/04/17 download Created with Sketch. 394.72KB Share MSB Successful Interim Analysis in Phase 3 Heart Failure Trial 10/04/17 PRICE SENSITIVE download Created with Sketch. 369.91KB Share MSB Mesoblast Receives A$3.7m From Aus Govt For R&D 06/04/17 PRICE SENSITIVE download Created with Sketch. 65.87KB Share MSB FDA Clears Heart Disease Trial At Boston Childrens Hospital 04/04/17 PRICE SENSITIVE download Created with Sketch. 93.12KB Share MSB Change in substantial holding 03/04/17 download Created with Sketch. 317.03KB Share MSB Becoming a substantial holder from TEK 31/03/17 download Created with Sketch. 110.17KB Share MSB Cleansing notice and Appendix 3B 31/03/17 download Created with Sketch. 234.09KB Share MSB Process Initiated For CHF P3 Interim Analysis 31/03/17 PRICE SENSITIVE download Created with Sketch. 92.03KB Share MSB Mesoblast Raises US$40 Million 27/03/17 PRICE SENSITIVE download Created with Sketch. 90.92KB Share MSB Durable Three Year Outcomes in Disc Disease 15/03/17 PRICE SENSITIVE download Created with Sketch. 104.05KB Share